The Healing Harmony: Study shows Taichi's positive impact on glycemic control and lung diffusion capacity in type 2 diabetes Medha Baranwal22 April 2024 10:00 AM ISTUSA: Taichi training or Taichi plus resistance band training effectively improves blood glycemic control and pulmonary diffusion capacity in patients...
Poorly Controlled Type 1 Diabetes in children linked to MASLD irrespective of overweight: Study Dr Riya Dave14 April 2024 9:30 PM ISTRecent research study has highlighted the intricate connection between metabolic dysfunction associated with steatotic liver disease (MASLD) and...
Advancing therapy with iGlarLixi safe and effective for diabetes treatment irrespective of SGLT2 inhibitors use: Study Medha Baranwal3 April 2024 2:15 AM ISTA patient-level pooled analysis of three randomized clinical trials (RCTs) revealed improvement in glycemic status without increased risk of...
Evergreen Talk Series: How can Safety and Tolerability of Linagliptin and Dapagliflozin benefit diverse T2DM population? MD Brand Connect25 March 2024 4:38 PM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Growth hormone mediators linked with unique phenotype of pediatric type 2 diabetes: TODAY analysis Medha Baranwal14 March 2024 3:00 AM ISTUSA: A post hoc secondary analysis of a randomized clinical trial (TODAY) of 398 participants with youth-onset type 2 diabetes (T2D) revealed that...
Evergreen Talk Series: Combination of Linagliptin and Dapagliflozin in T2DM with multiple episodes of hypoglycemia MDTV Bureau21 Feb 2024 9:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Evergreen Talk Series: Use of SGLT2i and DPP4i combination in T2DM patients with a history of Genitourinary Tract Infections MD Brand Connect1 Feb 2024 10:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
Empagliflozin and semaglutide combination improves glycemic control and BP but not arterial stiffness Jacinthlyn Sylvia1 Feb 2024 10:15 AM ISTA recent 32-week study investigated the effects of empagliflozin, semaglutide, and their combination on vascular function. This study published in the...
Evergreen Talk Series: Position paper published in JAPI indicated that Linagliptin is simplifying T2DM management in a Wide Range of Patients MDTV Bureau23 Jan 2024 11:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Evergreen Talk Series: Clinical Considerations for Linagliptin and its combinations with Metformin, Dapagliflozin MD Brand Connect2 Jan 2024 11:00 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
Evergreen Talk Series: Linagliptin and Dapagliflozin combination for T2DM with Cardiovascular risk or established ASCVD MD Brand Connect21 Dec 2023 11:45 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr. Sameer I. Dani,...
Long-term blood sugar control may not affect macrovascular atherosclerosis in type 1 diabetes patients: Study Medha Baranwal12 Dec 2023 11:45 AM ISTFinland: A recent study published in Acta Diabetologica revealed no association between long-term blood glucose control and carotid intima-media...
